Document is current
Any future updates will be listed below
-
Authors
Lund, Ken https://orcid.org/0000-0002-3959-2926
Knudsen, Torben
Kjeldsen, Jens
Nielsen, Rasmus Gaardskær
Juhl, Carsten Bogh
Nørgård, Bente Mertz
-
Funding
Funding for this research was provided by:
Pfizer
The Region of Southern Denmark
TrygFonden
The Region of Southern Denmark
Aage og Johanne Louis-Hansens Fond
The Danish Colitis Crohn Foundation
Odense University Hospital Research Council
University Library of Southern Denmark
- License Information
-
More Information
Article History
Received: 27 December 2021
Accepted: 6 November 2023
First Online: 20 November 2023
Declarations
:
: This study protocol has been approved by the Regional Ethics Committee of Southern Denmark (Journal number: S-20200003) and includes an informed consent form for the patients to participate in the study.
: Not applicable
: JK has received lecture fees from Tillotts and Ferring. TK has received lecture fees from Pfizer, Takeda, and Janssen Pharma. TK is an advisory board member at Janssen Pharma and Takeda. The remaining authors declare that they have no competing interests.
